Takafumi Watanabe Selected Research

Takafumi Watanabe Research Topics

Disease

34	Neoplasms (Cancer) 11/2021 - 09/2002
8	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 10/2002
7	Stomach Neoplasms (Stomach Cancer) 01/2021 - 06/2011
6	Esophageal Neoplasms (Esophageal Cancer) 05/2020 - 11/2011
5	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2011
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2021 - 08/2015
4	Inflammation (Inflammations) 01/2021 - 03/2013
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 08/2018
4	Hemorrhage 01/2021 - 11/2012
2	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 07/2022 - 01/2019
2	Carcinogenesis 10/2020 - 03/2004
2	Shock 10/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 11/2012
2	Carcinoma (Carcinomatosis) 08/2013 - 10/2012
1	Spontaneous Abortion (Miscarriage) 04/2022
1	Anovulation 04/2022
1	Trisomy (Trisomies) 10/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2021
1	Autistic Disorder (Autism) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Pathologic Processes 01/2021
1	Residual Neoplasm 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2020
1	Hypoglycemia (Reactive Hypoglycemia) 07/2020
1	Poult Enteritis Mortality Syndrome 07/2020
1	Melanoma (Melanoma, Malignant) 05/2020
1	Lymphatic Metastasis 05/2020
1	Infertility (Sterility) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Surgical Blood Loss 10/2019
1	Cognitive Dysfunction 02/2019
1	Alzheimer Disease (Alzheimer's Disease) 02/2019
1	Bronchogenic Cyst 01/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
4	Biological ProductsIBA 04/2021 - 11/2013
4	CytokinesIBA 01/2017 - 11/2004
3	Messenger RNA (mRNA)IBA 04/2021 - 06/2012
3	ClaudinsIBA 04/2021 - 09/2020
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 10/2002
3	CollagenIBA 01/2021 - 05/2006
3	Cisplatin (Platino)FDA LinkGeneric 05/2020 - 10/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2013
2	Dermatan SulfateIBA 07/2022 - 01/2019
2	FibrinIBA 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 08/2013
2	nedaplatinIBA 09/2020 - 08/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2018 - 10/2012
2	C-Reactive ProteinIBA 02/2014 - 03/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2013 - 08/2012
1	Racemases and Epimerases (Epimerases and Racemases)IBA 07/2022
1	GonadotropinsIBA 04/2022
1	Hormones (Hormone)IBA 04/2022
1	entrectinibIBA 04/2022
1	dichlorobis(azomycin)platinum IIIBA 10/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021
1	AntibodiesIBA 04/2021
1	LigandsIBA 01/2021
1	serum-glucocorticoid regulated kinaseIBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 12/2020
1	Ophthalmic Solutions (Eye Drops)IBA 10/2020
1	claudin 6IBA 09/2020
1	PlatinumIBA 09/2020
1	olaparibIBA 09/2020
1	Blood Glucose (Blood Sugar)IBA 07/2020
1	phosphatidyl-N-monomethylaminoethanolIBA 05/2020
1	Drug CombinationsIBA 05/2020
1	Docetaxel (Taxotere)FDA Link 05/2020
1	Fluorouracil (Carac)FDA LinkGeneric 05/2020
1	RamucirumabIBA 02/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 10/2019
1	2-aminoethylmethacrylate (AEM)IBA 10/2019
1	Amyloid beta-PeptidesIBA 02/2019
1	Amyloid (Amyloid Fibrils)IBA 02/2019
1	Antineoplastic Agents (Antineoplastics)IBA 08/2018

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2021 - 11/2010
7	Therapeutics 04/2022 - 09/2002
4	Adjuvant Chemotherapy 01/2012 - 06/2008
3	Gastrectomy 11/2021 - 06/2011
3	Chemoradiotherapy 05/2020 - 08/2013
3	Cystectomy 01/2019 - 01/2015
3	Neoadjuvant Therapy 11/2017 - 10/2012
2	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 05/2020
2	Esophagectomy 05/2020 - 04/2018
2	Radiotherapy 03/2020 - 11/2015
2	Length of Stay 10/2019 - 01/2014
2	Trachelectomy 08/2015 - 08/2015
2	Immunotherapy 07/2015 - 11/2012
2	Laparotomy 01/2013 - 06/2008
1	Aftercare (After-Treatment) 04/2021
1	Hysterectomy 10/2020
1	Operative Surgical Procedures 05/2020
1	Intravenous Infusions 05/2020
1	Salpingo-oophorectomy 04/2020
1	Stents 02/2020
1	Pelvic Exenteration 10/2019